The biphotonic cervical cancer scan is approved in the EU, Canada, Singapore ....
FDA meeting on May 8th and approval soon thereafter (look for the pps to quadruple).
International sales will accelerate as the year progresses.
Lots of distributors have been signed up the the evaluations are winding down.
Once it starts rolling, sales will mushroom.
The profit margins on the disposables used in each scan are 90%.
It's the Gillette model.
The new CEO is a marketing whiz formerly wit GE and Abbott.
Approval in the US is inevitable and it will be huge.
Over 60 million PAP smear tests are taken annually.
GTHP's scan is noninvasive, more accurate and produces instant test results.